Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper-Reference-Cited by-同舟云学术

Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper

Published:2017-05-04 Issue:7 Volume:72 Page:1035-1042
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Pfaar O.¹²^ORCID,Calderon M. A.³⁴,Andrews C. P.⁵,Angjeli E.⁶,Bergmann K. C.⁷,Bønløkke J. H.⁸^ORCID,de Blay F.⁹¹⁰,Devillier P.¹¹^ORCID,Ellis A. K.¹²¹³^ORCID,Gerth van Wijk R.¹⁴,Hohlfeld J. M.¹⁵^ORCID,Horak F.¹⁶,Jacobs R. L.⁵,Jacobsen L.¹⁷,Jutel M.¹⁸¹⁹,Kaul S.²⁰,Larché M.²¹,Larenas-Linnemann D.²²²³^ORCID,Mösges R.²⁴^ORCID,Nolte H.²⁵,Patel P.²⁶,Peoples L.⁶,Rabin R. L.²⁷^ORCID,Rather C.⁵,Salapatek A. M.²⁶,Sigsgaard T.⁸,Thaarup S.²⁸,Yang J.²⁹,Zieglmayer P.¹⁶^ORCID,Zuberbier T.³⁰,Demoly P.³¹³²

Affiliation:

1. Department of Otorhinolaryngology, Head and Neck Surgery; Universitätsmedizin Mannheim; Medical Faculty Mannheim; Heidelberg University; Mannheim Germany

2. Center for Rhinology and Allergology; Wiesbaden Germany

3. Section of Allergy and Clinical Immunology; Imperial College London; London UK

4. National Heart & Lung Institute; Royal Brompton Hospital; London UK

5. Biogenics Research Chamber LLC; San Antonio TX USA

6. Ora, Inc.; Andover MA USA

7. Allergy-Centre-Charité; Charité Universitätsmedizin Berlin; Berlin Germany

8. Department of Public Health; Section for Environment, Occupation and Health; Danish Ramazzini Center; Aarhus University; Aarhus Denmark

9. ALYATEC; Strasbourg France

10. Chest Disease Department; University Hospital of Strasbourg and Federation of Translational Medicine, EA3072; Strasbourg University; Strasbourg France

11. UPRES EA 220; Airway Diseases Department; Hôpital Foch; Université Versailles Saint Quentin; University Paris Saclay; Suresnes France

12. Department of Medicine; Queen's University; Kingston ON Canada

13. Environmental Exposure Unit; Kingston General Hospital; Kingston ON Canada

14. Section of Allergology; Department of Internal Medicine; Erasmus MC; Rotterdam The Netherlands

15. Department of Clinical Airway Research; Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM); Hannover Germany, Member of the German Center for Lung Research

16. Vienna Challenge Chamber; Vienna Austria

17. Allergy Learning and Consulting (ALC); Copenhagen Denmark

18. ALL-MED Medical Research Institute; Wrocław Poland

19. Wroclaw Medical University; Wrocław Poland

20. Division of Allergology; Paul-Ehrlich-Institut; Federal Institute for Vaccines and Biomedicines; Langen Germany

21. Firestone Institute for Respiratory Health; Department of Medicine; St. Joseph's Hospital Healthcare; McMaster University; Hamilton ON Canada

22. Department of Investigation; Hospital Médica Sur; Mexico City Mexico

23. Center for Excellence in Asthma and Allergy; Mexico City Mexico

24. Institute of Medical Statistics, Informatics and Epidemiology (IMSIE); University Hospital of Cologne; University at Cologne; Cologne Germany

25. Merck&Co; Kenilworth NJ USA

26. Inflamax Research Inc.; Mississauga ON Canada

27. Center for Biologics Evaluation and Research; United States Food and Drug Administration; Silver Spring MD USA

28. Mobile Chamber Experts GmbH (MCX); Berlin Germany

29. Red Maple Trials; Ottawa ON Canada

30. Global Allergy and Asthma European Network (GA LEN); Department of Dermatology & Allergy; Charité Universitätsmedizin Berlin; Berlin Germany

31. Département de Pneumologie et Addictologie; Hôpital Arnaud de Villeneuve; University Hospital of Montpellier; Montpellier France

32. UPMC Paris 06; UMR-S 1136; IPLESP; Equipe EPAR; Sorbonne Universités; Paris France

Funder

EAACI

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13133/fullpdf

Reference39 articles.

1. Environmental exposure chambers in allergen immunotherapy trials: current status and clinical validation needs;Rösner-Friese;J Allergy Clin Immunol,2015

2. European Medicines Agency Committee for medicinal products for human use (CHMP): Guideline on the Clinical Development of Products for Specific Immunotherapy for The Treatment of Allergic Diseases (CHMP/EWP/18504/2006) 2008 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003605.pdf

3. The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy;Devillier;Allergy,2011

4. Controlled allergen challenge facilities and their unique contributions to allergic rhinitis research;North;Curr Allergy Asthma Rep,2015

5. Factors that affect the allergic rhinitis response to ragweed allergen exposure;Ellis;Ann Allergy Asthma Immunol,2010

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical validation of grass pollen exposure chamber in patients with allergic rhinitis triggered by timothy grass;Clinical & Experimental Allergy;2024-04-14

2. Efficacy of 300 IR house dust mite immunotherapy as a function of disease activity: Tertile analysis in clinical trials;Clinical & Experimental Allergy;2024-03-28

3. Wirksamkeit und Sicherheit des Kombinations-Nasensprays Olopatadinhydrochlorid-Mometasonfuroat bei der Behandlung der allergischen Rhinitis;Allergo Journal;2024-02

4. Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis;Allergo Journal International;2024-01-22

5. Clinical Relevance of <i>Lepidoglyphus destructor</i> Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment;International Archives of Allergy and Immunology;2024